COMMUNIQUÉS West-GlobeNewswire

CAMP4 Announces an Oversubscribed Private Placement of up to $100 Million to Advance First-in-Class Treatment for SYNGAP1-Related Disorders
10/09/2025
Oversubscribed Financing led by Coastlands Capital with participation from new and existing investors Financing to provide $50 million in upfront proceeds with the potential for up to an additional $50 million of [...]
Bioversys Reports Corporate Highlights and Key Financials For the First Half 2025
10/09/2025
BV100: successful end of Phase 2 meeting with US FDA following Positive Phase 2 read-out in Ventilator-Associated Bacterial Pneumonia (VABP); Phase 3 on track to initiate in 2025; Formulation patent granted in China, [...]
Pharming Group promoted to the Euronext AMX® index
10/09/2025
Leiden, the Netherlands, September 10, 2025: Pharming Group N.V. (“Pharming” or “the Company”) (Euronext: PHARM; Nasdaq: PHAR) today announced that it has been promoted from the Euronext AScX® (Small Cap) to the AMX® ( [...]
Communiqué de presse : Tzield approuvé en Chine comme premier traitement modificateur de la maladie pour les patients adultes et pédiatriques atteints de diabète de type 1 au stade 2
10/09/2025
Tzield approuvé en Chine comme premier traitement modificateur de la maladie pour les patients adultes et pédiatriques atteints de diabète de type 1 au stade 2 Approbation basée sur l’étude TN-10, qui démontre la [...]
Press Release: Tzield approved in China as first disease-modifying therapy for adult and pediatric patients with stage 2 type 1 diabetes
10/09/2025
Tzield approved in China as first disease-modifying therapy for adult and pediatric patients with stage 2 type 1 diabetes Approval based on the TN-10 study, demonstrating Tzield’s ability to delay the onset of stage 3 [...]
Novo Nordisk to streamline operations and reinvest for growth
10/09/2025
Transformation to increase speed and redirect resources to growth opportunities within diabetes and obesity, aiming at reaching millions of untreated patients Intention to reduce ~9,000 roles globally with the [...]
Zelluna Announces Investor Forum on Science & Strategy to be held on Wednesday 17 September 2025
10/09/2025
Oslo, Norway, 10 September 2025 – Zelluna (OSE: ZLNA), a company pioneering allogeneic ‘off the shelf’ T Cell Receptor based Natural Killer (TCR-NK) cells for the treatment of cancer, announces an Investor Science and [...]
Asabys Partners Leads €10 Million Extension of SafeHeal’s Oversubscribed Series C Financing to Accelerate Commercialization of Colovac®
10/09/2025
Asabys joins SafeHeal’s global investor syndicate, which includes Sofinnova, Solar Eclipse and a Leading Multinational Life Sciences Corporation, bringing additional resources and strategic expertise to advance pivotal [...]
Dogecoin Cash, Inc. Subsidiary PrestoDoctor Now Accepts Cryptocurrency Payments, Including Dogecoin
10/09/2025
MESQUITE, NV, Sept. 10, 2025 (GLOBE NEWSWIRE) -- September 10, 2025 – Mesquite, NV – Dogecoin Cash, Inc. ($CBDS), a publicly traded leader in blockchain innovation,announced that its wholly owned subsidiary, [...]
IPG Health expands Influencer ID marketing expertise into Europe
10/09/2025
Strategic rollout will scale US success into key European markets, strengthening the network’s leadership of social media strategy in the health/pharma sector LONDON, Sept. 10, 2025 (GLOBE NEWSWIRE) -- IPG Health is [...]
#1 Vendor to Order Metronidazole Online in the UK [2025 Guide]
10/09/2025
In today’s digital age, online pharmacies have become a convenient avenue for accessing medications. One popular drug commonly sold online is Metronidazole for humans. It is a widely used antibiotic known for its [...]
Where To Buy Ivermectin For Humans in 2025: Discover The Best Online Pharmacy For Over-The-Counter Drugs
10/09/2025
In the ongoing discussions, understanding the role of Ivermectin in human medical treatment remains critical, especially considering its potential to address conditions like parasitic infections and its controversial [...]
How to Get a Modafinil Prescription | A-Z Online Guide 2025
10/09/2025
Modafinil has garnered a reputation as a remarkable cognitive enhancer, making it a topic of great interest among professionals, students, and individuals seeking to optimize their productivity and mental acuity. Its [...]
Dianthus Therapeutics, Inc. Announces Pricing of Upsized $251 Million Underwritten Public Offering
10/09/2025
NEW YORK and WALTHAM, Mass., Sept. 09, 2025 (GLOBE NEWSWIRE) -- Dianthus Therapeutics, Inc. (Nasdaq: DNTH), a clinical-stage biotechnology company dedicated to advancing the next generation of antibody complement [...]
Telix Doses First Patient in Phase 3 BiPASS Trial: PSMA-PET Imaging for Prostate Cancer Diagnosis
10/09/2025
MELBOURNE, Australia and INDIANAPOLIS, Sept. 10, 2025 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, “Telix”) today announces it has dosed the first patient in a Phase 3 clinical trial aimed [...]
Rapport Announces Pricing of Public Offering of Common Stock
10/09/2025
BOSTON and SAN DIEGO, Sept. 09, 2025 (GLOBE NEWSWIRE) -- Rapport Therapeutics, Inc. (Nasdaq: RAPP) (“Rapport” or the “Company”), a clinical-stage biotechnology company dedicated to the discovery and development of small [...]
KFSHRC Concludes Strategic Role at C3 Davos of Healthcare New York Summit
09/09/2025
NEW YORK, Sept. 09, 2025 (GLOBE NEWSWIRE) -- King Faisal Specialist Hospital & Research Centre (KFSHRC) concluded its participation as Strategic Partner and strategic partner of the C3 Davos of Healthcare™ New York [...]
Tevogen Estimates 5-Year Top-Line Revenue of ∼$6.5 Billion For Product Focused on Liver Cancer Prevention with High-Risk Chronic Hepatitis B Infection
09/09/2025
Risk adjusted Net Present Value (rNPV) for TVGN 116 is estimated to exceed ~$325 million in the US alone. WARREN, N.J., Sept. 09, 2025 (GLOBE NEWSWIRE) -- Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN [...]
Serina Therapeutics Secures Up to $20 Million to Advance Registrational Trial of SER-252 in Parkinson’s Disease
09/09/2025
Transaction structured to provide flexible funding to support Phase 1b registrational clinical study program in advanced Parkinson’s under the 505(b)(2) NDA pathway Evaluating complementary funding including strategic [...]

Pages